Alterations of IGF-binding proteins in patients with alcoholic liver cirrhosis

被引:17
作者
Nedic, O
Nikolic, JA
Hajdukovic-Dragojlovic, L
Todorovic, V
Masnikosa, R
机构
[1] Inst Appl Nucl Energy, INEP, YU-11080 Zemun, Yugoslavia
[2] Inst Med Res, Belgrade, Yugoslavia
关键词
IGF; binding proteins; glycosylation; liver cirrhosis;
D O I
10.1016/S0741-8329(00)00090-2
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The protein synthetic activity of the liver is diminished in cirrhosis. The aim of this study was to investigate possible changes in the serum IGF-IGFBP system among patients with alcoholic liver cirrhosis (ALC). The results obtained demonstrated that serum IGF-I and IGF-II concentrations were significantly lower in patients with ALC than in healthy persons (P = 0.0008 for IGF-1 and 0.0002 for IGF-II). The IGFBP profile was markedly altered and the 34 kDa IGFBP from patients had higher affinity towards I-125-IGF-II compared to the 34 kDa IGFBP of control individuals. Moreover, the 40-45 kDa IGFBP (in isolated complex with I-125-IGF-II) exhibited diminished interaction with concanavalin A, wheat Semi, and breadfruit lectins. Modification of the glyco-component of the 40-45 kDa IGFBP seems to be an early event in ALC since change in reactivity towards lectins was noticed in patients with ALC classified as Child score A, whose serum IGF-I and IGF-II levels were within reference limits (the existence of carbohydrate microheterogeneity of this IGFBP was also assessed by lectin-affinity electrophoresis). It is possible that these biochemical alterations may affect the functional activity of the IGFs by changing the dynamics and distribution of these growth factors in the organism. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:223 / 229
页数:7
相关论文
共 27 条
[1]   Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis [J].
Assy, N ;
Hochberg, Z ;
Amit, T ;
ShenOrr, Z ;
Enat, R ;
Baruch, Y .
JOURNAL OF HEPATOLOGY, 1997, 27 (05) :796-802
[2]  
BLUM WF, 1993, GROWTH REGULAT, V3, P100
[3]   Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3 [J].
Booth, BA ;
Boes, M ;
Dake, BL ;
Bar, RS .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 276 (03) :E450-E454
[4]   The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus [J].
Cheetham, TD ;
Holly, JMP ;
Baxter, RC ;
Meadows, K ;
Jones, J ;
Taylor, AM ;
Dunger, DB .
JOURNAL OF ENDOCRINOLOGY, 1998, 157 (01) :81-87
[5]   Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3 [J].
Firth, SM ;
Ganeshprasad, U ;
Baxter, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (05) :2631-2638
[6]   Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3 [J].
Firth, SM ;
Baxter, RC .
JOURNAL OF ENDOCRINOLOGY, 1999, 160 (03) :379-387
[7]  
Firth Sue M., 1995, Progress in Growth Factor Research, V6, P223, DOI 10.1016/0955-2235(95)00009-7
[8]  
Goldstein I.J., 1986, LECTINS PROPERTIES F, P35, DOI DOI 10.1016/B978-0-12-449945-4.50007-5
[9]   Differential expression of IGF-I and IGF-binding protein-1 and -2 in periportal and perivenous zones of rat liver [J].
Hazel, SJ ;
Nordqvist, ACS ;
Hall, K ;
Nilsson, M ;
Schalling, M .
JOURNAL OF ENDOCRINOLOGY, 1998, 157 (02) :285-294
[10]  
Holt RIG, 1997, HEPATOLOGY, V26, P1600